January 13.2025
2 Minutes Read

Survival Rates Improve in Nevus-Associated vs. De Novo Acral Melanoma

Survival Rates Improve in Nevus-Associated vs. De Novo Acral Melanoma


Understanding the Differences in Melanoma

In a recent study published by Yiqun Zhang and colleagues, it was found that patients with nevus-associated acral melanoma (NAAM) demonstrated better survival rates compared to those with de novo acral melanoma (DNAM). This distinction between melanoma types is crucial for medical practitioners to tailor treatment and communication strategies effectively.

Significant Findings from the Study

The study, focusing on 684 native Chinese patients undergoing radical surgery, unveiled that individuals with NAAM had a five-year recurrence-free survival rate of 55.1%, contrasted with those diagnosed with DNAM at 42.3%. Additionally, overall survival rates also differed, standing at 75.1% for NAAM patients versus 63.2% for their DNAM counterparts. These figures highlight the potential for better prognoses and emphasize the importance of differentiating between types of acral melanomas.

Relevance to Concierge Medical Practices

For those running concierge medical practices, these findings present an opportunity to improve patient engagement by offering more personalized and informed care. Understanding that NAAM patients have better survival outcomes could help in discussing prognosis and treatment plans with patients, fostering a deeper trust and connection.

Unique Benefits of This Knowledge

Knowing these distinctions allows concierge physicians to provide more comprehensive education to their patients, potentially enhancing overall care quality. This understanding might not only aid in establishing trust with patients but also position practices favorably as forward-thinking, patient-centered, and leading in offering up-to-date medical insights.

Actionable Insights and Practical Tips

Medical practice owners are encouraged to utilize survival statistics in developing targeted communications, potentially leading to more successful patient outcomes and satisfaction. Incorporating these insights into regular patient consultations and discussions about melanoma screenings could make a significant impact on patient decision-making and health management.


Write A Comment

*
*

This website contains content that has been created using AI. Results created through the use of AI can be inaccurate, unreliable, and subject to hallucinations. Concierge Health Hub disclaims any and all liability arising from use of its AI tool or services. Results created through the use of AI are generally not protectable under intellectual property law, so Users assume all risk associated with potential liability and non-protectability arising from its use. For further details, see the Terms, available here.